A New Material Design Aims to Keep Transplanted Insulin-Producing Cells Alive

Type 1 diabetes occurs when the immune system attacks and destroys the beta cells in the pancreas that produce insulin. Without these cells, the body cannot regulate blood sugar, requiring people with Type 1 diabetes to manage their condition through insulin therapy and careful monitoring.

One long-term research goal is to replace lost beta cells through transplantation. However, getting transplanted cells to survive and function after they are implanted into the body remains a major challenge.

When beta cells are first implanted, they may not immediately receive enough blood supply to deliver adequate oxygen. This oxygen shortage can damage or kill the transplanted cells before new blood vessels can form to support them.

To protect cells during this critical early period, researchers have been exploring ways to encapsulate, or wrap, the cells in special gel-like materials that can shield them from immune attack while keeping them alive.

Researchers created a hydrogel—a water-based gel material—using alginate (a natural substance derived from seaweed), graphene oxide (a form of carbon), and calcium peroxide (a compound that releases oxygen). They also added a stabilizing layer of poly-L-lysine.

The key innovation was incorporating calcium peroxide as an oxygen-releasing system. This allows the gel to continuously deliver oxygen to the enclosed cells during the critical early days after implantation, when the transplant has not yet established its own blood supply.

In laboratory tests, the research team evaluated how well beta cells survived and functioned within different versions of the hydrogel. The hydrogels remained stable for eight days while continuously releasing oxygen.

The best results came with a hydrogel containing 0.25% calcium peroxide. At this concentration, beta cells maintained good survival and continued to multiply over 96 hours. The cells also preserved their ability to respond to glucose and release insulin appropriately—a critical measure of beta cell function.

Interestingly, a higher concentration of calcium peroxide (1%) actually harmed cell survival, suggesting that oxygen delivery needs to be carefully balanced. Too much oxygen can be as problematic as too little.

These results come from controlled laboratory experiments with cells grown in dishes. The research team describes this work as a promising step toward future preclinical and clinical testing.

Much work remains before such a system could be used in people with Type 1 diabetes. The next phases would typically involve testing in animal models and then, if safe and effective, eventually in human trials. This type of research often takes many years to translate from the laboratory into clinical practice.

Source: Macromolecular bioscience. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.